Muzaffer Demir

1.3k total citations
77 papers, 918 citations indexed

About

Muzaffer Demir is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Muzaffer Demir has authored 77 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 17 papers in Internal Medicine and 15 papers in Surgery. Recurrent topics in Muzaffer Demir's work include Venous Thromboembolism Diagnosis and Management (17 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Platelet Disorders and Treatments (9 papers). Muzaffer Demir is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (17 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Platelet Disorders and Treatments (9 papers). Muzaffer Demir collaborates with scholars based in Türkiye and United States. Muzaffer Demir's co-authors include Burhan Turgut, Sibel Güldiken, Gülsüm Emel Pamuk, Özden Vural, Armağan Tuğrul, Nilda Turgut, Babürhan Güldiken, Ender Arıkan, Jawed Fareed and Ahmet Tezel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Muzaffer Demir

75 papers receiving 877 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Muzaffer Demir 207 164 136 133 131 77 918
Geneviève Plu‐Bureau 116 0.6× 402 2.5× 142 1.0× 122 0.9× 40 0.3× 27 1.5k
Monika Safford 71 0.3× 143 0.9× 41 0.3× 63 0.5× 103 0.8× 15 1.1k
Shanshan Chu 97 0.5× 318 1.9× 119 0.9× 107 0.8× 100 0.8× 33 1.0k
Anna Paola Cellai 356 1.7× 255 1.6× 41 0.3× 147 1.1× 149 1.1× 35 1.0k
Ewa Wypasek 223 1.1× 429 2.6× 31 0.2× 271 2.0× 209 1.6× 107 1.3k
F. Keller 139 0.7× 116 0.7× 38 0.3× 255 1.9× 121 0.9× 35 806
Jessica N. Cooke Bailey 182 0.9× 140 0.9× 34 0.3× 99 0.7× 319 2.4× 64 1.7k
J.K. Radder 150 0.7× 436 2.7× 45 0.3× 240 1.8× 144 1.1× 34 1.4k
Ralf Knöfler 682 3.3× 148 0.9× 30 0.2× 134 1.0× 88 0.7× 69 1.1k
Yahya İslamoğlu 28 0.1× 258 1.6× 72 0.5× 127 1.0× 73 0.6× 41 585

Countries citing papers authored by Muzaffer Demir

Since Specialization
Citations

This map shows the geographic impact of Muzaffer Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffer Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffer Demir more than expected).

Fields of papers citing papers by Muzaffer Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffer Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffer Demir. The network helps show where Muzaffer Demir may publish in the future.

Co-authorship network of co-authors of Muzaffer Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffer Demir. A scholar is included among the top collaborators of Muzaffer Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffer Demir. Muzaffer Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
2.
Tezel, Ahmet & Muzaffer Demir. (2012). Inflammatory Bowel Disease and Thrombosis. SHILAP Revista de lepidopterología. 29(2). 111–119. 4 indexed citations
3.
Pamuk, Gülsüm Emel, et al.. (2011). Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients?. Journal of Thrombosis and Thrombolysis. 33(2). 154–159. 9 indexed citations
4.
Tekgündüz, Emre, et al.. (2011). Sticky platelet syndrome in patients with unexplained venous thrombosis. SHILAP Revista de lepidopterología. 30(1). 48–52. 8 indexed citations
5.
Demir, Muzaffer & Emre Tekgündüz. (2010). Antitrombotik ve Antikoagülan Kullanım İlkeleri. Balkan Medical Journal. 2010(1). 69–73. 1 indexed citations
6.
Aktöz, Meryem, Tevfik Aktoz, Ersan Tatlı, et al.. (2010). Original research Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndrome. Archives of Medical Science. 2(2). 168–175. 7 indexed citations
7.
Aktoz, Tevfik, Meryem Aktöz, Ersan Tatlı, et al.. (2010). Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease. International Urology and Nephrology. 42(4). 873–879. 11 indexed citations
8.
Pamuk, Gülsüm Emel, et al.. (2010). Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study. Blood Coagulation & Fibrinolysis. 21(2). 113–117. 12 indexed citations
9.
Duran, Rıdvan, et al.. (2009). Transient leukoerythroblastosis in a very low birth weight infant with parvovirus B19 infection. International Journal of Infectious Diseases. 13(6). e473–e475. 5 indexed citations
10.
Tuğrul, Armağan, et al.. (2008). The Relationship Between Proinflammatory Cytokine Levels and Fibrinolytic System in Obese Patients. Balkan Medical Journal. 2008(1). 44–51. 2 indexed citations
11.
Ağırbaşlı, Mehmet, et al.. (2008). Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer. Journal of Thrombosis and Thrombolysis. 27(2). 172–174. 1 indexed citations
12.
Güldiken, Babürhan, Sibel Güldiken, Muzaffer Demir, Nilda Turgut, & Armağan Tuğrul. (2008). Low Leptin Levels in Migraine: A Case Control Study. Headache The Journal of Head and Face Pain. 48(7). 1103–1107. 51 indexed citations
13.
Pamuk, Gülsüm Emel, et al.. (2008). EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies. Annals of Hematology. 87(4). 305–310. 33 indexed citations
14.
Demir, Muzaffer, et al.. (2007). The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients. Canadian Journal of Cardiology. 23(8). 651–655. 13 indexed citations
15.
Turgut, Burhan, et al.. (2007). 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. Leukemia & lymphoma. 48(2). 311–320. 20 indexed citations
16.
Pamuk, Gülsüm Emel, et al.. (2006). Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia. Leukemia Research. 31(8). 1149–1151. 15 indexed citations
17.
Pamuk, Gülsüm Emel, Özden Vural, Burhan Turgut, et al.. (2006). Increased circulating platelet–neutrophil, platelet–monocyte complexes, and platelet activation in patients with ulcerative colitis: A comparative study. American Journal of Hematology. 81(10). 753–759. 57 indexed citations
18.
Pamuk, Gülsüm Emel, et al.. (2006). The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. American Journal of Hematology. 81(8). 631–633. 11 indexed citations
19.
Çetın, Mustafa, Süleyman Buyukberber, Muzaffer Demir, et al.. (2005). Overexpression of cyclooxygenase‐2 in multiple myeloma: Association with reduced survival. American Journal of Hematology. 80(3). 169–173. 26 indexed citations
20.
Çermik, Tevfik Fikret, et al.. (2001). Bone Metastasis from Primary Splenic Angiosarcoma to the Sacrum Demonstrated by Tc-99m–Labeled Red Blood Cell and Tc-99m MDP Bone Scintigraphy. Clinical Nuclear Medicine. 26(4). 363–364. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Plu‐Bureau Breakdown of academic impact, for papers by Monika Safford Breakdown of academic impact, for papers by Shanshan Chu Breakdown of academic impact, for papers by Anna Paola Cellai Breakdown of academic impact, for papers by Ewa Wypasek Breakdown of academic impact, for papers by F. Keller Breakdown of academic impact, for papers by Jessica N. Cooke Bailey Breakdown of academic impact, for papers by J.K. Radder Breakdown of academic impact, for papers by Ralf Knöfler Breakdown of academic impact, for papers by Yahya İslamoğlu
Rankless by CCL
2026